Valuation: Fresenius SE & Co. KGaA

Market Cap 23.53B 26.91B 21.7B 19.95B 37.8B 2,589B 38.45B 259B 102B 1,266B 101B 98.84B 4,362B P/E 2026 *
12.5x
P/E 2027 * 11.2x
Enterprise Value 33.88B 38.75B 31.25B 28.73B 54.43B 3,728B 55.36B 373B 146B 1,822B 146B 142B 6,281B EV / Sales 2026 *
1.43x
EV / Sales 2027 * 1.33x
Free-Float
72.98%
Yield 2026 *
2.72%
Yield 2027 * 2.96%
1 day-0.54%
1 week-1.97%
Current month+3.55%
1 month+6.76%
3 months-6.34%
6 months-16.94%
Current year-15.50%
1 week 40.4
Extreme 40.4
43.17
1 month 38.42
Extreme 38.42
44.07
Current year 35.11
Extreme 35.11
52.96
1 year 35.11
Extreme 35.11
52.96
3 years 23.93
Extreme 23.93
52.96
5 years 19.69
Extreme 19.69
52.96
10 years 19.69
Extreme 19.69
80.07
Manager TitleAgeSince
Chief Executive Officer 57 01/10/2022
Director of Finance/CFO 46 01/09/2022
Compliance Officer 50 -
Director TitleAgeSince
Director/Board Member 71 20/05/2015
Chairman 71 21/05/2021
Director/Board Member 65 13/05/2016
Date Insider Type Main position Quantity % Market Cap.
28/05Buy

Chief Executive Officer

160 0.0000%
28/05Buy

Chief Executive Officer

790 0.0001%
28/05Buy

Chief Executive Officer

276 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%-1.97%+1.10%+58.46% 26.91B
-0.25%+1.38%+65.64%+48.37% 135B
+4.19%-7.73%+1.90%+27.75% 84.04B
-2.05%-3.09%+21.24%+43.67% 22.34B
+0.99%+0.42%-16.45%-28.25% 19.8B
+4.71%-6.75%+11.32%+134.85% 16.57B
-0.11%+5.66%+6.95%+12.67% 15.58B
-0.34%+0.39%+64.81%+123.26% 14.87B
-0.53%-0.19%-10.00%-12.29% 12.8B
-0.34%-0.20%-13.17%+79.58% 11.15B
Average +0.25%-1.19%+13.33%+48.81% 35.92B
Weighted average by Cap. +0.64%-1.71%+28.38%+44.14%

Financials

2026 *2027 *
Net sales 23.62B 27.02B 21.79B 20.03B 37.95B 2,600B 38.6B 260B 102B 1,271B 101B 99.24B 4,379B 24.83B 28.41B 22.91B 21.06B 39.9B 2,733B 40.59B 274B 107B 1,336B 107B 104B 4,605B
Net income 1.89B 2.17B 1.75B 1.61B 3.04B 209B 3.1B 20.87B 8.19B 102B 8.14B 7.96B 351B 2.12B 2.43B 1.96B 1.8B 3.41B 234B 3.47B 23.38B 9.17B 114B 9.12B 8.92B 394B
Net Debt 10.35B 11.84B 9.55B 8.78B 16.63B 1,139B 16.91B 114B 44.72B 557B 44.45B 43.48B 1,919B 9.6B 10.98B 8.86B 8.14B 15.42B 1,056B 15.69B 106B 41.48B 516B 41.23B 40.33B 1,780B
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (37.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc.; - other (3.1%).
Employees
177,783
Date Price Change Volume
16/07/26 EUR 41.42 -0.84% 154,348
15/07/26 EUR 41.77 +1.83% 694,868
14/07/26 EUR 41.02 -1.61% 775,204
13/07/26 EUR 41.69 -2.07% 819,141
10/07/26 EUR 42.57 +0.83% 1,049,701
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
41.77EUR
Average target price
54.22EUR
Spread / Average Target
+29.81%

Quarterly revenue - Rate of surprise